You are here

Article info

Article menu
Download PDFPDF
Colorectal
Case report
Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy

Authors

  1. Correspondence to Dr Anil Prabhu, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK; anil_prabhu{at}hotmail.co.uk
View Full Text

Citation

Chauhan D, Prabhu A, Cripps S, et al
Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy
Frontline Gastroenterology 2023;14:432-434.

Publication history

  • Received January 6, 2023
  • Accepted March 17, 2023
  • First published March 27, 2023.
Online issue publication 
January 23, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.